Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Hindalco 170.00 0.06
Bhel 239.00 0.73
Ntpc Ltd 138.10 0.29
Tata Stl 514.35 0.16
Axis Ban 403.70 1.61
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Biocon Limited
Biocon Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:532523NSE:BIOCONBloomberg:BIOS@INReuters:BION.BO
Market Lot: 1Face Value: 5ISIN Demat: INE376G01013
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
11-AUG-14 Biocon kicked off a series of patient outreach programs to mark a Decade of Excellence in affordable insulin therapy, through which it has been touching the lives of lakhs of diabetic patient. 25-JUL-14 Total Income has increased by 2.6% to Rs. 7,419.50 million for the quarter ended June 30, 2014 from Rs. 7,231.70 million for the same quarter last year. 03-JUN-14 Bristol-Myers Squibb and Syngene International, a Biocon`s arm, tod...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Biocon gains after unit extends drug discovery partnership  -IRIS 04-Jun-14
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Jun-2014(3)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 5346.0020980.7018374.80
Other Income117.40605.80514.70
Total Income5463.4021586.5018889.50
Cost of goods sold4422.9017292.4015323.10
OPBDIT1040.504294.103566.40
PAT746.303298.502757.00
Gross Block---
Equity capital1000.001000.001000.00
EPS (Rs.)-16.5314.08
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-16.00 - 30.0914.78 - 22.83
Debt / Equity (x)---
Operating margin (% of OI)19.019.918.9
Net margin (% of OI)13.715.314.6
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
20th KM, Hosur Road
Electronics City Post Office
Bangalore
Karnataka-560 100
PHONE
(080) 2808 2808/ 3037
FAX
(080) 2852 3423
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer